Lund Vasculitis Epidemiology Research Group

Forskningsoutput

Forskningsoutput per år 2016 2021 2022 2023

• 27 Artikel i vetenskaplig tidskrift
• 5 Konferensabstract
• 4 Publicerat konferensabstract
• 4 Doktorsavhandling (sammanläggning)
• 3 Mer
  • 2 Översiktsartikel
  • 1 Letter

Forskningsoutput per år

Forskningsoutput per år

Sökresultat

• 2023

  Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study

  Rathmann, J., Segelmark, M., Englund, M. & Mohammad, A., 2023 mars 9, I: RMD Open. 9, 1, s. 1-8 e002949.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 100%
  • Vasculitis 71%
  • Sweden 67%
  • Granulomatosis with Polyangiitis 43%
  • Antibodies 38%

• Stratified Genetic Analysis Reveals Sex Differences In MPO-ANCA-associated Vasculitis

  Ekman, D., Sennblad, B., Knight, A., Karlsson, Å., Rantapää-Dahlqvist, S., Berglin, E., Stegmayr, B., Baslund, B., Palm, Ø., Haukeland, H., Gunnarsson, I., Bruchfeld, A., Segelmark, M., Ohlsson, S., Mohammad, A. J., Svärd, A., Pullerits, R., Herlitz, H., Söderbergh, A., Omdal, R., & 5 andraJonsson, R., Rönnblom, L., Eriksson, P., Lindblad-Toh, K. & Dahlqvist, J., 2023 apr. 2, (E-pub ahead of print) I: Rheumatology (Oxford, England). s. 1-6

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 100%
  • Antineutrophil Cytoplasmic Antibodies 86%
  • Peroxidase 66%
  • Sex Characteristics 64%
  • Myeloblastin 38%
• 2022

  Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study

  Johansson, L., Berglin, E., Eriksson, O., Mohammad, A. J., Dahlqvist, J. & Rantapää-Dahlqvist, S., 2022, I: Scandinavian Journal of Rheumatology. 51, 3, s. 214-219

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 100%
  • Myeloblastin 99%
  • Complement Activation 78%
  • Peroxidase 66%
  • Antineutrophil Cytoplasmic Antibodies 32%

• Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes

  Wiberg, F., Naderi, N., Mohammad, A. J. & Turesson, C., 2022 jan. 1, I: Rheumatology (United Kingdom). 61, 1, s. 383-387 5 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Giant Cell Arteritis 100%
  • Phenotype 46%
  • Retrospective Studies 17%
  • Systemic Vasculitis 16%
  • Rheumatologists 15%

• Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA

  Dahlqvist, J., Ekman, D., Sennblad, B., Kozyrev, S. V., Nordin, J., Karlsson, Å., Meadows, J. R. S., Hellbacher, E., Rantapää-Dahlqvist, S., Berglin, E., Stegmayr, B., Baslund, B., Palm, Ø., Haukeland, H., Gunnarsson, I., Bruchfeld, A., Segelmark, M., Ohlsson, S., Mohammad, A. J., Svärd, A., & 15 andraPullerits, R., Herlitz, H., Söderbergh, A., Rosengren Pielberg, G., Hultin Rosenberg, L., Bianchi, M., Murén, E., Omdal, R., Jonsson, R., Eloranta, M-L., Rönnblom, L., Söderkvist, P., Knight, A., Eriksson, P. & Lindblad-Toh, K., 2022, I: Rheumatology (Oxford, England). 61, 8 , s. 3461-3470

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 100%
  • Antineutrophil Cytoplasmic Antibodies 86%
  • Vasculitis 71%
  • Peroxidase 66%
  • Odds Ratio 27%

• Infection is associated with increased risk of MPO- but not PR3-ANCA associated vasculitis

  Rathmann, J., Stamatis, P., Jönsson, G., Englund, M., Segelmark, M., Jayne, D. R. W. & Mohammad, A., 2022, I: Rheumatology (Oxford, England). 61, 12 , s. 4817-4826

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 100%
  • Myeloblastin 99%
  • Vasculitis 71%
  • Peroxidase 66%
  • Infections 33%

• Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

  Bettiol, A., Mohammad, A. J., Yacyshyn, E. & European EGPA Study Group, 2022, I: Arthritis and Rheumatology. 74, 2, s. 295-306

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • mepolizumab 100%
  • Granulomatosis with Polyangiitis 74%
  • Multicenter Studies 51%
  • Observational Studies 46%
  • Asthma 23%

• Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis

  Esberg, A., Johansson, L., Berglin, E., Mohammad, A. J., Jonsson, A. P., Dahlqvist, J., Stegmayr, B., Johansson, I. & Rantapää-Dahlqvist, S., 2022, I: Microorganisms. 10, 8, 1572.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Vasculitis 100%
  • Microbiota 96%
  • Neutrophils 76%
  • Immunoglobulin G 20%
  • Periodontitis 15%

• The Role of Sural Nerve Biopsy in the Diagnosis of Vasculitis

  Gisslander, K., Dahlin, L. B., Smith, R., Jayne, D., O’Donovan, D. G. & Mohammad, A. J., 2022 sep. 1, I: Journal of Rheumatology. 49, 9, s. 1031-1036 6 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Sural Nerve 100%
  • Vasculitis 81%
  • Biopsy 48%
  • Pathology 11%
  • Antineutrophil Cytoplasmic Antibodies 11%
• 2021

  Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply

  Stamatis, P., Turkiewicz, A., Englund, M., Turesson, C. & Mohammad, A., 2021, I: Rheumatology (Oxford, England). 60, 11, s. e423-e424

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Giant Cell Arteritis 100%
  • Sweden 75%
  • Epidemiology 60%
  • Biopsy 46%
  • Incidence 37%

• Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden - an update on incidence and first prevalence estimate

  Stamatis, P., Turkiewicz, A., Englund, M., Turesson, C. & Mohammad, A., 2021, I: Rheumatology. 61, 1, s. 146-153

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Giant Cell Arteritis 100%
  • Sweden 75%
  • Epidemiology 60%
  • Biopsy 46%
  • Incidence 37%

• High risk of coronary artery aneurysm in Kawasaki disease

  Mossberg, M., Mohammad, A. J., Kahn, F., Segelmark, M. & Kahn, R., 2021, I: Rheumatology (Oxford, England). 60, 4, s. 1910-1914 5 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Coronary Aneurysm 100%
  • Mucocutaneous Lymph Node Syndrome 91%
  • Coronary Vessels 59%
  • Child 24%
  • Intravenous Immunoglobulins 17%

• Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.

  Rathmann, J., Jayne, D. R., Segelmark, M., Jönsson, G. & Mohammad, A., 2021 juni 1, I: Rheumatology (Oxford, England). 60, 6, s. 2745-2754 10 s., keaa699.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 100%
  • Cohort Studies 47%
  • Incidence 33%
  • Infections 33%
  • Population 27%

• Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study

  Mohammad, A. J., Turkiewicz, A., Stamatis, P., Turesson, C., Englund, M. & Kiadaliri, A., 2021, I: The Journal of rheumatology. 48, 8, s. 1307-1313

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Venous thromboembolism in ANCA-associated vasculitis: A population-based cohort study

  Liapi, M., Jayne, D., Merkel, P. A., Segelmark, M. & Mohammad, A. J., 2021 okt. 1, I: Rheumatology (United Kingdom). 60, 10, s. 4616-4623 8 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 100%
  • Venous Thromboembolism 74%
  • Cohort Studies 47%
  • Incidence 29%
  • Population 27%
• 2020

  Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study

  Turkiewicz, A., Stamatis, P. & Mohammad, A. J., 2020, I: RMD Open. 6, 2, e001285.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Cardiovascular Agents 100%
  • Giant Cell Arteritis 99%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 74%
  • Case-Control Studies 61%
  • Biopsy 46%

• Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis

  Weiner, M., Goh, S. M., Mohammad, A., Hruškova, Z., Tanna, A., Sharp, P., Kang, A., Bruchfeld, A., Selga, D., Chocova, Z., Westman, K., Eriksson, P., Harper, L., Pusey, C. D., Tesar, V., Salama, A. D. & Segelmark, M., 2020, I: Journal of Rheumatology. 47, 4, s. 580-588

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Microscopic Polyangiitis 100%
  • Granulomatosis with Polyangiitis 84%
  • Hospitalization 49%
  • Elderly 45%
  • Rituximab 31%

• Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden

  Stamatis, P., Turkiewicz, A., Englund, M., Jönsson, G., Nilsson, J-Å., Turesson, C. & Mohammad, A., 2020 maj, I: Journal of Rheumatology. 47, 6

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Giant Cell Arteritis 100%
  • Sweden 75%
  • Case-Control Studies 61%
  • Infections 36%
  • Population 30%

• Malignancies In Giant Cell Arteritis: A Population-Based Cohort Study

  Stamatis, P., Turesson, C., Willim, M., Nilsson, J-Å., Englund, M. & Mohammad, A. J., 2020, I: Journal of Rheumatology. 47, 7, s. 400-406

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Giant Cell Arteritis 100%
  • Cohort Studies 52%
  • Population 30%
  • Neoplasms 24%
  • Upper Gastrointestinal Tract 21%
• 2019

  Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis

  Teixeira, V., Mohammad, A. J., Jones, R. B., Smith, R. & Jayne, D., 2019, I: RMD Open. 5, 1, e000905.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Granulomatosis with Polyangiitis 100%
  • Rituximab 86%
  • Vasculitis 68%
  • Antineutrophil Cytoplasmic Antibodies 50%
  • Safety 46%
• 2018

  Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)

  Maritati, F., Fenoglio, R., Pillebout, E., Emmi, G., Urban, M. L., Rocco, R., Nicastro, M., Incerti, M., Goldoni, M., Trivioli, G., Silvestri, E., Mohammad, A. J., Jayne, D., Eriksson, P., Segelmark, M., Novikov, P., Harris, H., Roccatello, D. & Vaglio, A., 2018, I: Arthritis and Rheumatology. 70, 1, s. 109-114 6 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Rituximab 100%
  • Vasculitis 94%
  • Immunoglobulin A 86%
  • Prednisone 23%
  • Proteinuria 22%

• Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)

  Sjöwall, C., Mandl, T., Skattum, L. M., Olsson, M. & Mohammad, A., 2018 apr. 30, I: Rheumatology (Oxford, England). s. 1400–1407

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Vasculitis 100%
  • Epidemiology 76%
  • Scleritis 56%
  • University Hospitals 30%
  • Urticaria 22%

• Hospitalizations due to systemic connective tissue diseases: Secular trends and regional disparities in Sweden, 1998-2016

  Kiadaliri, A. A., Mohammad, A. J. & Englund, M., 2018 nov., I: International Journal of Rheumatic Diseases. 21, 11, s. 1900-1906

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Connective Tissue Diseases 100%
  • Sweden 81%
  • Hospitalization 61%
  • Polyarteritis Nodosa 37%
  • International Classification of Diseases 18%
• 2017

  Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: The influence of ANCA subtype

  Mohammad, A. J., Mortensen, K. H., Babar, J., Smith, R., Jones, R. B., Nakagomi, D., Sivasothy, P. & Jayne, D. R. W., 2017 okt. 1, I: Journal of Rheumatology. 44, 10, s. 1458-1467 10 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Antineutrophil Cytoplasmic Antibodies 100%
  • Vasculitis 81%
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 49%
  • Myeloblastin 49%
  • Tomography 46%

• Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis

  Mohammad, A. J., Segelmark, M., Smith, R., Englund, M., Nilsson, J-Å., Westman, K., Merkel, P. A. & Jayne, D. R. W., 2017 okt. 1, I: Journal of Rheumatology. 44, 10, s. 1468-1475 8 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Antineutrophil Cytoplasmic Antibodies 100%
  • Vasculitis 81%
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 41%
  • Infections 37%
  • Population 11%
• 2016

  Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population

  Englund, M., Merkel, P. A., Tomasson, G., Segelmark, M. & Mohammad, A. J., 2016 aug. 1, I: Journal of Rheumatology. 43, 8, s. 1553-1558 6 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Antineutrophil Cytoplasmic Antibodies 100%
  • Vasculitis 81%
  • Comorbidity 62%
  • Antibodies 38%
  • Population 31%

• Visual complications in patients with biopsy-proven giant cell arteritis: A population-based study

  Saleh, M., Turesson, C., Englund, M., Merkel, P. A. & Mohammad, A. J., 2016 aug. 1, I: Journal of Rheumatology. 43, 8, s. 1559-1565 7 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Giant Cell Arteritis 100%
  • Biopsy 46%
  • Population 30%
  • Adrenergic Agents 14%
  • Temporal Arteries 10%